Status: The MediSieve Haemofiltration System has completed pre-clinical trials, and first-in-man safety studies are planned for 2020. The first trials will be focused on safety, performing the procedure on healthy human volunteers. Once these are completed, we will conduct follow-on clinical trials with malaria patients.